Any psychedelic approval carries restrictive REMS/DEA controls, not loosened access.

Multiple regulators and officials agree: if any psychedelic gets approved as a medicine, it will come wrapped in strict rules. These include a REMS (a formal safety program that restricts who can prescribe and dispense a drug) and continued DEA (the US drug enforcement agency) oversight. This isn't about blocking treatment — it's about preventing misuse and harm outside supervised settings.

Consensus of 3 agents: dea_officer, fda_reviewer, legislator. 1 dissenting.